Search results
Order by most recent / most popular / relevance
Results: 1-10 of 51
Patentability of medical treatment claims to be heard by U.S. Supreme Court
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 30 2011
The U.S. Supreme Court has agreed to review a Federal Circuit Court of Appeals ruling that methods for determining the optimal dosage of thiopurine drugs used to treat gastrointestinal and non-gastrointestinal autoimmune diseases recite patentable subject matter under 35 U.S.C. 101
Review denied on failed challenge to stem cell research funding order
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 16 2011
The U.S. Supreme Court has reportedly denied a petition asking it to review a Fourth Circuit Court of Appeals ruling that human embryos and those considering adopting human embryos lack standing to challenge President Barack Obama’s executive order removing restrictions on funding for embryonic stem cell research
Supplemental briefs filed in stem cell funding dispute
- Shook Hardy & Bacon LLP
- -
- USA
- -
- July 14 2011
The parties to a dispute over whether National Institutes of Health (NIH) guidelines on stem cell research violate a congressional appropriations rider that bars federal funding for research in which a human embryo is destroyed have filed their supplemental briefs on competing motions for summary judgment pending before a U.S. district court in Washington, D.C
Violations of discovery orders result in default judgment, monetary sanctions, potential discipline
- Shook Hardy & Bacon LLP
- -
- USA
- -
- August 18 2011
A federal court in Texas has imposed severe sanctions in a patent infringement lawsuit, due to repeated violations of its discovery orders and the creation of a fraudulent discovery-related document; a default judgment has been entered against the violator, and information about the document has been forwarded to alert the district’s chief judge “of the need to potentially take disciplinary measures” against counsel
Federal Circuit says certain human genes may be patented
- Shook Hardy & Bacon LLP
- -
- USA
- -
- August 4 2011
In a ruling likely to be appealed to the U.S. Supreme Court, a divided Federal Circuit Court of Appeals panel has determined that genetic discoveries may, to a certain extent, be patented
Court dismisses challenge to NIH stem cell research funding guidelines
- Shook Hardy & Bacon LLP
- -
- USA
- -
- August 4 2011
A federal district court in Washington, D.C., has dismissed a challenge to National Institutes of Health (NIH) guidelines on stem cell research funding. Sherley v. Sebelius, No. 09-1575 (U.S. Dist. Ct., D.D.C., decided July 27, 2011
Federal Circuit upholds fees, costs and sanctions in “patent troll” litigation
- Shook Hardy & Bacon LLP
- -
- USA
- -
- August 4 2011
The Federal Circuit Court of Appeals has determined that a district court correctly awarded litigation costs and attorney’s fees to the defendant in an infringement action found to be an “exceptional case” and had sufficient grounds to impose Rule 11 sanctions against the plaintiff, a company in the business of filing infringement actions to extract nuisance value settlements
Dialysis equipment maker sues component part supplier for indemnification
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 17 2011
A company that makes dialysis equipment for use in clinics and by patients in their homes has filed a complaint in federal court against a company that supplied a component part which allegedly contained a defect that led to a recall and caused injuries and at least one death
Third edition of judicial science guidelines published
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 7 2011
The Federal Judicial Center and National Research Council have issued the third edition of the Reference Manual on Scientific Evidence, which courts use to understand complex expert testimony and scientific evidence produced at trial
Parties to gene patent dispute change course by seeking U.S. Supreme Court review
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 20 2011
After filing petitions for rehearing before the Federal Circuit Court of Appeals panel that split over whether genetic discoveries can be patented, the parties have apparently changed course and indicated their intent to petition the U.S. Supreme Court for review
